The Enterprise Value as of December 2025 (TTM) for Talaris Therapeutics, Inc. (TALS) is 1.20B

According to Talaris Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.20B. This represents a change of 158.80% compared to the average of 464.20M of the last 4 quarters.

Talaris Therapeutics, Inc. (TALS) Historical Enterprise Value (quarterly & annually)

How has TALS Enterprise Value performed in the past?

The mean historical Enterprise Value of Talaris Therapeutics, Inc. over the last ten years is 505.95M. The current 1.20B Enterprise Value has changed 23.64% with respect to the historical average. Over the past ten years (40 quarters), TALS's Enterprise Value was at its highest in in the March 2022 quarter at 1.05B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Talaris Therapeutics, Inc. (TALS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Talaris Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Talaris Therapeutics, Inc. (TALS) Average Enterprise Value

How has TALS Enterprise Value performed in the past?

The current Enterprise Value of Talaris Therapeutics, Inc. (TALS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Talaris Therapeutics, Inc. (TALS) Enterprise Value vs. Peers

How is TALS’s Enterprise Value compared to its peers?

Talaris Therapeutics, Inc.’s Enterprise Value is greater than Decibel Therapeutics, Inc. (102.82M), greater than HilleVax, Inc. (69.63M), greater than RVL Pharmaceuticals plc (16.09M), greater than Graybug Vision, Inc. (115.07M), greater than Kinnate Biopharma Inc. (71.17M), greater than Paratek Pharmaceuticals, Inc. (351.99M), greater than Pardes Biosciences, Inc. (75.90M), greater than NGM Biopharmaceuticals, Inc. (69.72M), greater than Cyteir Therapeutics, Inc. (-37516738.00), greater than Opiant Pharmaceuticals, Inc. (88.02M),

Build a custom stock screener for Talaris Therapeutics, Inc. (TALS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Talaris Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Talaris Therapeutics, Inc. (TALS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Talaris Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.